{
  "docId": "019de070-d3cd-70da-8da9-11fac56c0e6a",
  "docSlug": "a10c554cbe4a4cf1ea91fc4610f64010",
  "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 27 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 27,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-d3cd-70da-8da9-11fac56c0e6a/10",
  "deckHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a",
  "deckJsonHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a.json",
  "deckAnchorHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.13,
        "w": 0.24,
        "x": 0.74,
        "y": 0.04
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d8c7ba8-1579-4c6f-adb1-56c1f16f5ef1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.886,
        "x": 0.057,
        "y": 0.375
      },
      "kind": "list",
      "text": "ANA001 being studied in U.S. Phase 2/3 trial (currently enrolling patients)\nGeneric niclosamide used safely for 50+ years globally as a treatment for tapeworm infections\nNiclosamide prevents replication of SARS-CoV-2 at very low concentrations\nNiclosamide also shown to have three distinct mechanisms of action:",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3841918-827d-4397-874c-147f2b122192",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.868,
        "x": 0.075,
        "y": 0.62
      },
      "kind": "list",
      "text": "Potential Antiviral: Lowers SARS-CoV-2 and a broad homology of other virus including Influenza.\nAnti-Inflammatory: Unique MOA does not suppress immune system while reducing inflammation.\nBronchodilation: Useful mechanism for at-risk patients with underlying cardio/pulmonary conditions.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e76edf81-f7e1-45f8-adcd-6b9f004192bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.886,
        "x": 0.057,
        "y": 0.25
      },
      "kind": "title",
      "text": "Acquired proprietary capsule formulation of niclosamide for COVID-19 treatment and prophylaxis",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5c23fc44-f825-4dc5-9c7d-1c9eabdfeeda",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.085,
        "w": 0.163,
        "x": 0.057,
        "y": 0.038
      },
      "kind": "title",
      "text": "ANA001",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dc071e0-af95-427a-993a-01a811618202",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 9,
      "beatId": "8655d104-9188-4c3d-a61d-8b90df20fe7b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 9-10 discuss the problem of COVID-19 and the need for effective treatments.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    },
    {
      "to": 13,
      "from": 10,
      "beatId": "5169c810-3b0c-4740-947f-27f8b9f7e416",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 10-13 present ANA001 as a solution, including its mechanism of action and efficacy data.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}